Ident. | Authors (with country if any) | Title |
---|
000032 (2002) |
R. Dinwiddie [Royaume-Uni] ; N. Sharief ; O. Crawford | Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. |
000074 (1992) |
A. Bush [Royaume-Uni] ; M N Sheppard ; J O Warner | Chloroquine in idiopathic pulmonary haemosiderosis. |
000129 (1991) |
D A Spencer [Royaume-Uni] ; J F Price | A case of fibrosing alveolitis in childhood. |
000254 (2014) |
Sivan M. Bokobza [Royaume-Uni] ; Yanyan Jiang ; Anika M. Weber ; Aoife M. Devery ; Anderson J. Ryan [Royaume-Uni] | Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells. |
000266 (2014) |
Lisa Jolly [Royaume-Uni] ; Anastasios Stavrou [Royaume-Uni] ; Gilles Vanderstoken [Canada] ; Victoria A. Meliopoulos [États-Unis] ; Anthony Habgood [Royaume-Uni] ; Amanda L. Tatler [Royaume-Uni] ; Joanne Porte [Royaume-Uni] ; Alan Knox [Royaume-Uni] ; Paul Weinreb [États-Unis] ; Shelia Violette [États-Unis] ; Tracy Hussell [Royaume-Uni] ; Martin Kolb [Canada] ; Martin R. Stampfli [Canada] ; Stacey Schultz-Cherry [États-Unis] ; Gisli Jenkins [Royaume-Uni] | Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation. |
000300 (2015) |
Andrew Bush [Royaume-Uni] ; Steve Cunningham [Royaume-Uni] ; Jacques De Blic [France] ; Angelo Barbato [Italie] ; Annick Clement [France] ; Ralph Epaud [France] ; Meike Hengst [Allemagne] ; Nural Kiper [Turquie] ; Andrew G. Nicholson [Royaume-Uni] ; Martin Wetzke [Allemagne] ; Deborah Snijders [Italie] ; Nicolaus Schwerk [Allemagne] ; Matthias Griese [Allemagne] | European protocols for the diagnosis and initial treatment of interstitial lung disease in children. |
000447 (2018) |
Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour] | Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer. |
000502 (2019) |
Philippa M. Wells [Royaume-Uni] ; Frances M. K. Williams [Royaume-Uni] ; M. L. Matey-Hernandez [Royaume-Uni] ; Cristina Menni [Royaume-Uni] ; Claire J. Steves [Royaume-Uni] | ‘RA and the microbiome: do host genetic factors provide the link? |
000543 (2019) |
Peter. C. Taylor [Royaume-Uni] ; Alejandro Balsa Criado ; Anne-Barbara Mongey ; Jerome Avouac ; Hubert Marotte ; Rudiger B. Mueller | How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy |
000549 (2019) |
Peter C. Taylor ; Didier Saurigny [Royaume-Uni] ; Jiri Vencovsky [République tchèque] ; Tsutomu Takeuchi [Japon] ; Tadashi Nakamura [Japon] ; Galina Matsievskaia [Russie] ; Barbara Hunt [États-Unis] ; Thomas Wagner [Suisse] ; Bernard Souberbielle [Royaume-Uni] | Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial |
000558 (2019) |
Tommy Weiss-Sadan ; Gal Itzhak ; Farnusch Kaschani [Allemagne] ; Zhanru Yu [Royaume-Uni] ; Mohamed Mahameed ; Adi Anaki ; Yael Ben-Nun ; Emmanuelle Merquiol ; Boaz Tirosh ; Benedikt Kessler [Royaume-Uni] ; Markus Kaiser [Allemagne] ; Galia Blum | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation |
000605 (2019) |
Beth I. Wallace [États-Unis] ; Chelsea A. Harris ; Lu Wang ; Mochuan Liu ; Jung-Sheng Chen ; Chang-Fu Kuo [Royaume-Uni] ; Kevin C. Chung | Impact of Cumulative Corticosteroid Dosage on Preventable Hospitalization among Taiwanese Patients with Ankylosing Spondylitis and Inflammatory Bowel Disease |
000606 (2019) |
David Kuo [États-Unis] ; Jennifer Ding [États-Unis] ; Ian S. Cohn [États-Unis] ; Fan Zhang [États-Unis] ; Kevin Wei [États-Unis] ; Deepak A. Rao [États-Unis] ; Cristina Rozo [États-Unis] ; Upneet K. Sokhi [États-Unis] ; Sara Shanaj [États-Unis] ; David J. Oliver [États-Unis] ; Adriana P. Echeverria [États-Unis] ; Edward F. Dicarlo [États-Unis] ; Michael B. Brenner [États-Unis] ; Vivian P. Bykerk [États-Unis] ; Susan M. Goodman [États-Unis] ; Soumya Raychaudhuri [États-Unis, Royaume-Uni] ; Gunnar R Tsch [Suisse, États-Unis] ; Lionel B. Ivashkiv [États-Unis] ; Laura T. Donlin [États-Unis] | HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness |
000607 (2019) |
Cindy S. Chu [Thaïlande, Royaume-Uni] ; Germana Bancone [Thaïlande, Royaume-Uni] ; Nay Lin Soe [Thaïlande] ; Verena I. Carrara [Thaïlande, Suisse] ; Gornpan Gornsawun [Thaïlande] ; François Nosten [Thaïlande, Royaume-Uni] | The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis |
000615 (2019) |
Mercedes Segovia [Uruguay] ; Sofia Russo [Uruguay] ; Mathias Jeldres [Uruguay] ; Yamil D. Mahmoud [Argentine] ; Valentina Perez [Uruguay] ; Maite Duhalde [Uruguay] ; Pierre Charnet [France] ; Matthieu Rousset [France] ; Sabina Victoria [Uruguay] ; Florencia Veigas [Argentine] ; Cédric Louvet [France] ; Bernard Vanhove [France] ; R. Andrés Floto [Royaume-Uni] ; Ignacio Anegon [France] ; Maria Cristina Cuturi [France] ; M. Romina Girotti [Argentine] ; Gabriel A. Rabinovich [Argentine] ; Marcelo Hill [Uruguay] | Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation |
000762 (2019) |
Marina Bacci [Italie] ; Nicla Lorito [Italie] ; Luigi Ippolito [Italie] ; Matteo Ramazzotti [Italie] ; Simone Luti [Italie] ; Simone Romagnoli [Italie] ; Matteo Parri [Italie] ; Francesca Bianchini [Italie] ; Federica Cappellesso [Belgique] ; Federico Virga [Belgique, Italie] ; Qiong Gao [Royaume-Uni] ; Bruno M. Sim Es [Royaume-Uni] ; Elisabetta Marangoni [France] ; Lesley-Ann Martin [Royaume-Uni] ; Giuseppina Comito [Italie] ; Manuela Ferracin [Italie] ; Elisa Giannoni [Italie] ; Massimiliano Mazzone [Belgique] ; Paola Chiarugi [Italie] ; Andrea Morandi [Italie] | Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer |
000967 (2019) |
M. J. Cuadrado [Royaume-Uni] ; I. Calatayud [Royaume-Uni] ; M. Urquizu-Padilla [Royaume-Uni] ; S. Wijetilleka [Royaume-Uni] ; S. Kiani-Alikhan [Royaume-Uni] ; M. Y. Karim [Qatar] | Immunoglobulin abnormalities are frequent in patients with lupus nephritis |
000981 (2020) |
Thomas Mcdonnell [Royaume-Uni] ; Chris Wincup [Royaume-Uni] ; Ina Buchholz [Allemagne] ; Charis Pericleous [Royaume-Uni] ; Ian Giles [Royaume-Uni] ; Vera Ripoll [Royaume-Uni] ; Hannah Cohen [Royaume-Uni] ; Mihaela Delcea [Allemagne] ; Anisur Rahman [Royaume-Uni] | The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS |
000A05 (2019) |
Jennifer Bryant [Royaume-Uni] ; Nikolaos Batis [Royaume-Uni] ; Anna Clara Franke [Royaume-Uni] ; Gabriella Clancey [Royaume-Uni] ; Margaret Hartley [Royaume-Uni] ; Gordon Ryan [Royaume-Uni] ; Jill Brooks [Royaume-Uni] ; Andrew D. Southam [Royaume-Uni] ; Nicholas Barnes [Royaume-Uni] ; Joanna Parish [Royaume-Uni] ; Sally Roberts [Royaume-Uni] ; Farhat Khanim [Royaume-Uni] ; Rachel Spruce [Royaume-Uni] ; Hisham Mehanna [Royaume-Uni] | Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma |
000A24 (2019) |
Rebecca Carter [Royaume-Uni] ; Azadeh Cheraghchi-Bashi [Royaume-Uni] ; Adam Westhorpe [Royaume-Uni] ; Sheng Yu [Royaume-Uni] ; Yasmin Shanneik [Royaume-Uni] ; Elena Seraia [Royaume-Uni] ; Djamila Ouaret [Royaume-Uni] ; Yasuhiro Inoue [Japon] ; Catherine Koch [États-Unis] ; Jenny Wilding [Royaume-Uni] ; Daniel Ebner [Royaume-Uni] ; Anderson J. Ryan [Royaume-Uni] ; Francesca M. Buffa [Royaume-Uni] ; Ricky A. Sharma [Royaume-Uni] | Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
|
000A61 (2019) |
Michela Mazzon [Royaume-Uni] ; Mark Marsh [Royaume-Uni] | Targeting viral entry as a strategy for broad-spectrum antivirals |